Pages
Products

Panoply™ Human NRP1 Knockdown Stable Cell Line

For research use only. Not intended for any clinical use.

Cat. No. :   CSC-DC010632

Host Cell :   HEK293 (Hela and other cell types are also available) Validation :   Real-Time RCR

Inquire for Price

Cell Line Information

Safety and Packaging

Gene Information

Cat. No. CSC-DC010632
Description Creative Biogene's Knockdown Cell Lines are target specific shRNA lentivirus transduced cells. The percent knockdown levels range from 75-99% depending on the gene, as evaluated by Real-Time RCR. Cells are rigorously qualified and mycoplasma free.
Target Gene NRP1
Host Cell HEK293 (Hela and other cell types are also available)
Host Cell Species Homo sapiens (Human)
Applications

(1) Studying gene functions

(2) Studying gene interactions and signaling pathways

(3) Target validation and drug discovery

(4) Designing diseases models

Size >1 × 106 cells / vial
Stability Validated for at least 10 passages
Validation Real-Time RCR
Quality Control Negative for bacteria, yeast, fungi and mycoplasma.
Storage Liquid Nitrogen
Shipping Dry Ice
Mycoplasma Negative
Format One frozen vial containing millions of cells
Storage Liquid nitrogen
Safety Considerations The following safety precautions should be observed.
1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum.
2. No eating, drinking or smoking while handling the stable line.
3. Wash hands after handling the stable line and before leaving the lab.
4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells.
5. All waste should be considered hazardous.
6. Dispose of all liquid waste after each experiment and treat with bleach.
Ship Dry ice
Gene Name NRP1 neuropilin 1 [ Homo sapiens ]
Gene Symbol NRP1
Synonyms NRP1; neuropilin 1; neuropilin-1; CD304; NRP; VEGF165R; transmembrane receptor; vascular endothelial cell growth factor 165 receptor; NP1; BDCA4; DKFZp781F1414; DKFZp686A03134;
Gene ID 8829
Uni Prot ID O14786
m RNA Refseq BC007737
Chromosome Location 10p12
Function coreceptor activity; cytokine binding; growth factor binding; growth factor binding; heparin binding; metal ion binding; receptor activity; semaphorin receptor activity; vascular endothelial growth factor-activated receptor activity;
Pathway Axon guidance, organism-specific biosystem; Axon guidance, conserved biosystem; Axon guidance, organism-specific biosystem; CHL1 interactions, organism-specific biosystem; CRMPs in Sema3A signaling, organism-specific biosystem; Developmental Biology, organism-specific biosystem; HTLV-I infection, organism-specific biosystem;
MIM 602069
Quick Inquiry

Case Study

Q & A

Customer Reviews

Gastric cancer has a high mortality rate, and its complex molecular pathogenesis leads to poor treatment outcomes. Autophagy plays a dual role in cancer, both promoting and inhibiting it. Here, researchers first obtained autophagy-related genes from a human autophagy database, and then applied consensus clustering analysis to perform molecular subtype analysis on gastric cancer samples from the TCGA database. The genes obtained after subtype analysis were used to construct a risk prognostic model. Subsequently, principal component analysis (PCA) and tSNE were used to assess the risk score, and the results showed that the model had good discriminative ability for gastric cancer samples. Cox regression analysis and time-dependent ROC curve analysis showed that the model had good risk prediction ability. Finally, combining pairwise expression profile comparison analysis, Kaplan-Meier survival curves, and external validation on the GEO dataset, NRP1 was ultimately selected as the research subject. In vitro experiments showed that NRP1 can regulate the proliferation and autophagy of gastric cancer cells by affecting the Wnt/β-catenin signaling pathway. Similarly, in vivo experiments also showed that NRP1 can affect tumor growth in vivo. Therefore, the researchers proposed that NRP1, by regulating autophagy, can serve as a prognostic factor and therapeutic target for gastric cancer.

Researchers used qPCR to detect differential expression of NRP1 (Figure 1A). Next, they constructed a stable NRP1 knockdown cell line and used Western blot to detect the expression levels of NRP1, the cell proliferation marker Ki67, and the autophagy-related marker LC3I/II. As shown in Figure 1B, after NRP1 knockdown, Ki67 expression decreased, while the LC3II/LC3I ratio increased, suggesting that NRP1 knockdown may lead to reduced cell proliferation and upregulated autophagy. Based on this, the researchers performed EdU assays and autophagy labeling experiments. In NRP1 knockdown cells, cell proliferation decreased by approximately 20%, and autophagy intensity increased (Figures 1C-E). To provide more reliable evidence that NRP1 knockdown leads to autophagy, they fixed the treated cells and used transmission electron microscopy to image the number and morphological changes of autophagic vesicles. In NRP1 knockdown cells, the number of intracellular autophagic vesicles was significantly increased (Figure 1F).

Figure 1. Validation of NRP1's regulation of tumor autophagy and proliferative capacity in vitro.Figure 1. Validation of NRP1's regulation of tumor autophagy and proliferative capacity in vitro. (Yu Q Y, et al., 2023)

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction